Targeted inhibition of NNMT improves the energy metabolism of skeletal muscles and alleviates muscle damage caused by metabolic disorders through regulating the NAD+/AMPK axis in both the D‐galactose‐treated mouse model and the naturally aging mouse model. Here, NNMT is linked to metabolic disease.